Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 3
1982 3
1983 4
1984 6
1985 4
1986 5
1987 7
1988 9
1989 2
1990 7
1991 4
1992 3
1993 1
1994 2
1995 3
1996 2
1997 4
1998 7
1999 7
2000 4
2001 9
2002 6
2003 14
2004 8
2005 9
2006 29
2007 37
2008 44
2009 48
2010 61
2011 61
2012 53
2013 51
2014 56
2015 40
2016 71
2017 78
2018 90
2019 83
2020 114
2021 131
2022 132
2023 119
2024 61

Text availability

Article attribute

Article type

Publication date

Search Results

1,289 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1.
Chen S, Cui W, Chi Z, Xiao Q, Hu T, Ye Q, Zhu K, Yu W, Wang Z, Yu C, Pan X, Dai S, Yang Q, Jin J, Zhang J, Li M, Yang D, Yu Q, Wang Q, Yu X, Yang W, Zhang X, Qian J, Ding K, Wang D. Chen S, et al. Among authors: chi z. Cell Metab. 2022 Nov 1;34(11):1843-1859.e11. doi: 10.1016/j.cmet.2022.08.016. Epub 2022 Sep 13. Cell Metab. 2022. PMID: 36103895 Free article.
Ubiquitination of NLRP3 by gp78/Insig-1 restrains NLRP3 inflammasome activation.
Xu T, Yu W, Fang H, Wang Z, Chi Z, Guo X, Jiang D, Zhang K, Chen S, Li M, Guo Y, Zhang J, Yang D, Yu Q, Wang D, Zhang X. Xu T, et al. Among authors: chi z. Cell Death Differ. 2022 Aug;29(8):1582-1595. doi: 10.1038/s41418-022-00947-8. Epub 2022 Feb 2. Cell Death Differ. 2022. PMID: 35110683 Free PMC article.
Yuanzhuo C, Liao P, Chi Z, Shuai X, Deyi L. Yuanzhuo C, et al. Among authors: chi z. Urology. 2023 Jan;171:95. doi: 10.1016/j.urology.2022.08.051. Urology. 2023. PMID: 36610785 No abstract available.
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.
Sheng X, Yan X, Wang L, Shi Y, Yao X, Luo H, Shi B, Liu J, He Z, Yu G, Ying J, Han W, Hu C, Ling Y, Chi Z, Cui C, Si L, Fang J, Zhou A, Guo J. Sheng X, et al. Among authors: chi z. Clin Cancer Res. 2021 Jan 1;27(1):43-51. doi: 10.1158/1078-0432.CCR-20-2488. Epub 2020 Oct 27. Clin Cancer Res. 2021. PMID: 33109737 Clinical Trial.
The vasculature niches required for hematopoiesis.
Chi Z, Chen L, Ye X, Liu A, Yu G, Sun Y. Chi Z, et al. J Mol Med (Berl). 2022 Jan;100(1):53-61. doi: 10.1007/s00109-021-02155-2. Epub 2021 Oct 28. J Mol Med (Berl). 2022. PMID: 34709407 Review.
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial.
Mao L, Lian B, Li C, Bai X, Zhou L, Cui C, Chi Z, Sheng X, Wang X, Tang B, Yan X, Li S, Kong Y, Dai J, Wei X, Li J, Duan R, Xu H, Wu X, Yang Y, Cheng F, Zhang C, Xia F, Pang Z, Guo J, Si L. Mao L, et al. Among authors: chi z. JAMA Oncol. 2023 Aug 1;9(8):1099-1107. doi: 10.1001/jamaoncol.2023.1363. JAMA Oncol. 2023. PMID: 37261804 Clinical Trial.
1,289 results